Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance

2018/03/25 by Norah A. Terrault, Anna S.F. Lok, Brian J. McMahon +6 · 5 citations

paper · doi:10.1002/hep.29800

Cited by

• Predictive factors and clinical outcomes in decompensated non-cirrhotic chronic hepatitis B patients treated with entecavir or tenofovir disoproxil fumarate
• Chronic HDV Infection Shows Higher HBsAg Isoform Levels than HBV Infection, Paralleling HDV Replicative Activity
• De novo protein design: a transformative frontier in clinical protein applications
• Scientific and medical evidence informing expansion of hepatitis B treatment guidelines
• Patient and public health perspectives to inform expansion of hepatitis B treatment guidelines